載入...
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
Simon’s two-stage design and the admissible two-stage design have been commonly used in practice for single-arm phase II clinical trials when the primary endpoint is binary. The ethical benefit of the two-stage design over the single-stage design is attained by the early termination of the trial whe...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611508/ https://ncbi.nlm.nih.gov/pubmed/31303960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26981 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|